Logo ECIJA

    Life Sciences

    Sectors

    Leading health sciences consultancy with strategic vision and technical expertise.

    We advise major industry players in pharmaceuticals, vaccines, biotechnology, medical technology, medical devices, consumer health and health services.

    We advise our clients in the Life Sciences sector on their most complex and transformative issues. Our deep sector knowledge enables us to provide integrated and strategic advice, helping them navigate their most critical legal challenges. Our team includes lawyers with industry experience and specialised sector training.

    We provide our clients with a personalised and practical approach, combining in-depth industry knowledge with comprehensive legal advice to achieve their objectives in an efficient and workable manner.

    Our clients include pharmaceutical, biotechnology and medical device companies, as well as healthcare providers, regulatory bodies and academic institutions.

    Our team advises on a wide range of key industry issues and we offer a comprehensive and integrated service, with a multidisciplinary team covering all practice areas.

    At ECIJA, we are the strategic ally of the Life Sciences sector, guaranteeing an innovative and efficient approach to meet the legal challenges of the market.


    Insights

    Articles
    1 December 2024
    The impact of AI regulation on industrial relations

    The European AI Regulation marks a turning point in the field of work, establishing rules for a fair, ethical and non-discriminatory use of these technologies.

    Read more
    Articles
    14 March 2025
    Government to force companies to label AI content, with heavy penalties if they fail to do so

    Spain is preparing a law requiring labelling of AI-generated content, with fines of millions of dollars for non-compliance.

    Read more
    Articles
    4 March 2025
    Entrepreneurship (legally) in times of artificial intelligence

    The EU approves the first comprehensive legal framework for artificial intelligence, anticipating its mass adoption and setting ethical and legal limits to its development.

    Read more